Healthcare

Sensei Biotherapeutics is navigating a significant corporate transformation. The biotechnology firm has recently completed a comprehensive restructuring and integrated new...

After a period of significant price swings, Illumina's shares are showing signs of entering a more stable phase. A growing...

Investors in DuPont de Nemours are witnessing a company in the midst of a significant strategic evolution. As the firm...

The coming months represent a pivotal period for biopharmaceutical firm Axsome Therapeutics. As the company strategically expands its commercial capabilities,...

Following the release of its 2025 annual results, Protara Therapeutics has shifted investor attention squarely to its clinical pipeline. The...

Investors in Spero Therapeutics are closely monitoring the coming weeks, which could prove pivotal for the company’s fight against multidrug-resistant...

For income-focused investors, the announcement of a confirmed dividend payment from Universal Health Realty Income Trust provides a measure of...

A notable shift is occurring within the shareholder base of medical technology firm Fractyl Health. Specialized investment firms are accumulating...

Amazon is accelerating its artificial intelligence strategy with unprecedented financial commitments, fundamentally reshaping its growth narrative. The tech giant is...

Ahead of the quarterly dividend distribution scheduled for Tuesday, significant repositioning activity is being observed among major investors in UnitedHealth...